Clinical Information Search
Search Results for "gastroenterology_articles"
- Online Learning Center (0)
- Policy Library (9)
- Performance Measures (0)
- Annals of Internal Medicine (378)
- Annals of Internal Medicine: Clinical Cases (45)
- IM Matters (0)
- ACP Hospitalist (6)
- ACP Diabetes Monthly (0)
- ACP Gastroenterology Monthly (16)
Sorry, no results were found for "gastroenterology_articles" in Online Learning Center.
Sorry, no results were found for "gastroenterology_articles" in Performance Measures.
Displaying 231 - 240 of 378 in Annals of Internal Medicine
These Annals of Internal Medicine results only contain recent articles.
- Visit annals.org to search all content back to 1927.
- View Annals of Internal Medicine CME by topic here.
Aspirin use is associated with reduced risk for hepatocellular carcinoma
Source Citation Wang Y, Wang M, Liu C, et al. Aspirin use and the risk of hepatocellular carcinoma: a meta-analysis. J Clin Gastroenterol. 2022. [Epub ahead of print.] 35316225
ACG–CAG provided suggestions for periendoscopic management of anticoagulants and antiplatelets
Source Citation Abraham NS, Barkun AN, Sauer BG, et al. American College of Gastroenterology–Canadian Association of Gastroenterology clinical practice guideline: management of anticoagulants and antiplatelets during acute gastrointestinal bleeding and the periendoscopic period. Am J Gastroenterol. 2022;117:542-58. 35297395
In mild acute diverticulitis, outpatient therapy without antibiotics was noninferior to antibiotics
Source Citation Mora-López L, Ruiz-Edo N, Estrada-Ferrer O, et al. Efficacy and safety of nonantibiotic outpatient treatment in mild acute diverticulitis (DINAMO-study): a multicentre, randomised, open-label, noninferiority trial. Ann Surg. 2021;274:e435-42. 34183510
In hospitalized adults having colonoscopy, 1 L of bowel preparation was noninferior to 2-L or 4-L regimens for adequate bowel cleansing
Clinical Impact Ratings GIM/FP/GP: 5 out of 7 Gastroenterology: 5 out of 7
Inflammatory Bowel Disease
The global burden of inflammatory bowel diseases (IBD) continues to rise, placing increasing demands on primary care and specialty practices alike. Beyond disease control, patients with IBD face heightened risks related to chronic inflammation and long-term immunosuppressive therapy, including infection, cancer, bone loss, nutritional deficiencies, and mental health disorders. Proactive, structured health care maintenance encompassing vaccination, cancer screening, bone and cardiometabolic health, nutrition, and psychosocial well-being is essential to optimize long-term outcomes. Effective delivery of this care depends on close collaboration and clearly defined shared responsibilities between gastroenterologists and primary care physicians. This review outlines evidence-based strategies for health care maintenance in the outpatient management of adults with IBD.
How Would You Manage This Patient With Iron Deficiency Anemia? Grand Rounds Discussion From Beth Israel Deaconess Medical Center
Iron deficiency anemia (IDA) is the most common cause of anemia worldwide and a major cause of disability, manifesting with symptoms including fatigue, weakness, exercise intolerance, worsening heart failure, impaired concentration, irritability, and depression. Women of reproductive age are disproportionately affected due to menstrual blood loss and gynecologic disorders. Iron deficiency anemia is diagnosed in patients who have both iron deficiency (ID), noted by low ferritin level and/or transferrin saturation, and anemia. Notably, iron deficiency (ID) can also occur in the absence of anemia, and overreliance on hemoglobin thresholds may risk missing the diagnosis in menstruating women due to flawed sex-specific reference ranges. Work-up for ID and IDA should focus on identifying the underlying cause of anemia, and may include a gynecologic work-up, bidirectional endoscopy, testing for Helicobacter pylori infection and celiac disease, as well as administering a trial of iron. Iron deficiency can be treated with either oral or intravenous iron. Although several guidelines address the diagnosis or management of ID and IDA, they differ in their recommendations based on the population studied, the clinical context, and the quality of the underlying evidence. Here, 2 hematologists and coauthors of the 2025 Iron Consortium Guideline published in Lancet Haematology discuss areas of guideline uncertainty relating to the diagnosis, evaluation, and treatment of patients with IDA and for Ms. B, a young woman diagnosed with ID.
In inpatients with acute-on-chronic liver failure, suspicion- vs. investigation-based antifungal therapy increased survival at 28 d
Clinical Impact Ratings GIM/FP/GP: 5 out of 7 Gastroenterology: 6 out of 7 Critical Care: 5 out of 7